Re-treatment 225Ac-J591 for mCRPC

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT04576871
Phase: Early Phase 1
Trial Summary: The purpose of this study is to find out if re-treatment with 225Ac-J591 can be given without severe – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Weill Medical College of Cornell University
Acronym:

Pin It on Pinterest